494
Views
18
CrossRef citations to date
0
Altmetric
Research Articles

Metformin hydrochloride and wound healing: from nanoformulation to pharmacological evaluation

, , , , &
Pages 343-356 | Received 09 Aug 2018, Accepted 01 Dec 2018, Published online: 31 Jan 2019

References

  • Armengol, X., and Estelrich, J., 1995. Physical stability of different liposome compositions obtained by extrusion method. Journal of microencapsulation, 12 (5), 525–535.
  • Abd-Elbary, A., El-laithy, H.M., and Tadros, M.I., 2008. Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium. International journal of pharmaceutics, 357 (1-2), 189–198.
  • Abdelbary, G., and El-gendy, N., 2008. Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS pharmscitech, 9 (3), 740–747.
  • Alberti, K.G., and Zimmet, P.Z., 1998. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1 : diagnosis and classification of diabetes mellitus. Diabetic medicine, 15 (7), 539–553.
  • Attia, I.A., et al., 2007. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits. AAPS pharmscitech, 8 (4), E106.
  • Azeem, A., Anwer, M.K., and Talegaonkar, S., 2009. Niosomes in sustained and targeted drug delivery: some recent advances. Journal of drug targeting, 17 (9), 671–689.
  • Azmin, M.N., et al., 1985. The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice. The journal of pharmacy and pharmacology, 37 (4), 237–242.
  • Baillie, A.J., et al., 1985. The preparation and properties of niosomes-non-ionic surfactant vesicles . The journal of pharmacy and pharmacology, 37 (12), 863–868.
  • Balakrishnan, P., et al., 2009. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. International journal of pharmaceutics, 377 (1-2), 1–8.
  • Bancroft, J.D., Stevens, A., and Turner, D.R., 1996. Theory and practice of histological techniques. 4th ed. New York, NY: Churchill Livingstone.
  • Bennett, W.L., et al., 2011. Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Annals of Internal Medicine, 154 (9), 602–613.
  • Biswal, S., et al., 2008. Vesicles of non-ionic surfactants (niosomes) and drug delivery potential. International journal of pharmaceutical sciences and nanotechnology, 1 (1), 1–8.
  • Bretnall, A.E., and Clarke, G.S., 1998. Metformin hydrochloride. Analytical profiles of drug substances and excipients, 25 (C), 243–293.
  • Centis, V., and Vermette, P., 2008. Physico-chemical properties and cytotoxicity assessment of PEG-modified liposomes containing human hemoglobin. Colloids and surfaces B biointerfaces, 65 (2), 239–246.
  • Collier, C.A., et al., 2006. Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle. American journal of physiology. endocrinology and metabolism, 291 (1), E182–E189.
  • Costa, P., and Sousa Lobo, J.M., 2001. Modeling and comparison of dissolution profiles. European journal of pharmaceutical sciences, 13 (2), 123–133.
  • Dash, S., et al., 2010. Kinetic modeling on drug release from controlled drug delivery systems. Acta poloniae pharmaceutica, 67 (3), 217–223.
  • Desai, S.J., et al., 1966. Investigation of factors influencing release of solid drug dispersed in inert matrices. 3. Quantitative studies involving the polyethylene plastic matrix. Journal of pharmaceutical sciences, 55 (11), 1230–1234.
  • El-Nabarawi, M.A., et al., 2013. Transdermal drug delivery of paroxetine through lipid-vesicular formulation to augment its bioavailability. International journal of pharmaceutics, 443 (1-2), 307–317.
  • El-Ridy, M., et al., 2008. Niosomal encapsulation of the tuberculocidal drug rifampicin. Egypt Pharmaceutical Journal (NRC), 7 (January), 69–83.
  • El-Ridy, M.S., et al., 1988. The effect of surface charges of liposomes on aggregation in the buccal cavity. In: Proceeding of the 15th international symposium on controlled release of bioactive materials. Basel, Switzerland, 344.
  • El-Ridy, M.S., et al., 2007. Biological evaluation of pyrazinamide liposomes for treatment of Mycobacterium tuberculosis. International journal of pharmaceutics, 330 (1-2), 82–88.
  • El-Ridy, M.S., et al., 2011. Niosomal encapsulation of the antitubercular drug, pyrazinamide. Drug development and industrial pharmacy, 37 (9), 1110–1118.
  • El-Ridy, M.S., et al., 2014. In vitro and In vivo evaluation of niosomes containing Celecoxib. International journal of pharmaceutical sciences and research, 5 (11), 4677–4688.
  • Guidelines, T.P., 2015. Diabetes mellitus 1, (June), 1–11.
  • Hasan, A.A., Madkor, H., and Wageh, S., 2013. Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system. Drug delivery, 20 (3–4), 120–126.
  • Hashim, F., et al., 2010. Preparation and characterization of niosomes containing ribavirin for liver targeting. Drug delivery, 17 (5), 282–287.
  • Higuchi, T., 1963. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. Journal of pharmaceutical sciences, 52 (12), 1145–1149.
  • Hong, M., et al., 2009. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin. Journal of controlled release, 133 (2), 96–102.
  • Inzucchi, S.E., et al., 2012. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes care, 35 (6), 1364–1379.
  • Joshi, M., and Patravale, V., 2008. Nanostructured lipid carrier (NLC) based gel of celecoxib. International journal of pharmaceutics, 346 (1–2), 124–132.
  • Kerner, W., and Bruckel, J, 2014. Definition, classification and diagnosis of diabetes mellitus. Experimental and clinical endocrinology & diabetes, 122 (7), 384–386.
  • Khazaeli, P., Pardakhty, A., and Shoorabi, H., 2007. Caffeine-loaded niosomes: characterization and in vitro release studies. Drug delivery, 14 (7), 447–452.
  • Khuri, A.I., and Mukhopadhyay, S., 2010. Response surface methodology. Wiley interdisciplinary reviews: computational statistics, 2 (2), 128–149.
  • Kumar, G.P., and Rajeshwarrao, P., 2011. Nonionic surfactant vesicular systems for effective drug delivery — an overview. Acta pharmaceutica sinica B, 1 (4), 208–219.
  • Kumbhar, D., Wavikar, P., and Vavia, P., 2013. Niosomal gel of lornoxicam for topical delivery: in vitro assessment and pharmacodynamic activity. AAPS pharmscitech, 14 (3), 1072–1082.
  • Loghmani, E., 2005. Diabetes mellitus : type 1 and type 2. In: S.M. Stang, ed. Guidlines for adolescent nutrition services. 167–182.
  • Lohumi, A., et al., 2012. A novel drug delivery system: niosomes review. Journal of drug delivery and therapeutics, 2 (5), 129–135.
  • Loona, S., Gupta, N.B., and Khan, M.U., 2012. Preparation and characterization of metformin proniosomal gel for treatment of diabetes mellitus. International journal of pharmaceutical sciences review and research, 15 (2), 108–114.
  • Madhavi, M., Meher, C.P., Pochaiah, B., and Rao, A.M., 2013. Formulation and evaluation of metformin based niosomes. Journal of drug delivery, 2 (1), 1–7.
  • Mane, P.B., Antre, R.V., and Oswal, R.J., 2012. Review article antidiabetic drugs : an overview of diabetes. International journal of pharmaceutical and chemical sciences, 1 (1), 301–306.
  • Marianecci, C., et al., 2014. Niosomes from 80s to present: the state of the art. Advances in colloid and interface science, 205, 187–206.
  • Maruthur, N.M., et al., 2016. Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis. Annals of internal medicine, 164 (11), 740–751.
  • Mokhtar, M., et al., 2008. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. International journal of pharmaceutics, 361 (1–2), 104–111.
  • Najib, N., and Suleiman, M.S., 1985. The kinetics of drug release from ethylcellulose solid dispersions. Drug development and industrial pharmacy, 11 (12), 2169–2181.
  • Nasseri, B., 2005. Effect of cholesterol and temperature on the elastic properties of niosomal membranes. International journal of pharmaceutics, 300 (1-2), 95–101.
  • Padamwar, M.N., and Pokharkar, V.B., 2006. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability. International journal of pharmaceutics, 320 (1-2), 37–44.
  • Pakyari, M., et al., 2013. Critical role of transforming growth factor beta in different phases of wound healing. Advances in wound care, 2 (5), 215–224.
  • Palozza, P., et al., 2006. Solubilization and stabilization of beta-carotene in niosomes: delivery to cultured cells. Chemistry and physics of lipids, 139 (1), 32–42.
  • Pardakhty, A., Varshosaz, J., and Rouholamini, A., 2007. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. International journal of pharmaceutics, 328 (2), 130–141.
  • Parvin, S.K.G., et al., 2013. Review article: recent trends of novel drug delivery in treatment of diabetes mellitus. International journal of pharmaceutical archive, 2 (9), 224–232.
  • Pereira-Lachataignerais, J., et al., 2006. Study and formation of vesicle systems with low polydispersity index by ultrasound method. Chemistry and physics of lipids, 140 (1-2), 88–97.
  • Qaseem, A., et al., 2012. Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians. Annals of internal medicine, 156 (3), 218–231.
  • Saxena, P., et al., 2010. UV spectrophotometric method for the quatitation of metformin hyrochloride in pharmaceutical dosage form. Oriental journal of chemistry, 26 (4), 1553–1556.
  • Sentjurc, M., Vrhovnik, K., and Kristl, J., 1999. Liposomes as a topical delivery system: the role of size on transport studied by the EPR imaging method. Journal of controlled release, 59 (1), 87–97.
  • Sharma, R.K., et al., 2013. Solid lipid nanoparticles as a carrier of metformin for transdermal delivery. International journal of drug delivery, 5, 137–145.
  • Trinder, P., 1969. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Annals of clinical biochemistry, 6 (1), 24–27.
  • Umapathi, P., Ayyappan, J.D., and Darlin Quine, S., 2012. Quantitative determination of metformin hydrochloride in tablet formulation containing croscarmellose sodium as disintegrant by HPLC and UV spectrophotometry. Tropical journal of pharmaceutical research, 11 (1), 107–116.
  • Yusufoglu, H.S., et al., 2015. Antihyperglycemic and antihyperlipidemic effects of Ferula duranii in experimental type 2 diabetic rats. International journal of pharmacology, 11 (6), 532–541.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.